Preference for Artemisinin–based combination therapy among healthcare providers, Lokoja, North-Central Nigeria

[1]  J. Cunningham,et al.  Private sector malaria RDT initiative in Nigeria: lessons from an end-of-project stakeholder engagement meeting , 2018, Malaria Journal.

[2]  O. Amadi,et al.  Knowledge and Perception of Malaria Rapid Diagnostic Test among Medical Doctors in a South Eastern Nigeria Tertiary Hospital , 2017 .

[3]  Hong-Juan Peng,et al.  Risk of drug resistance in Plasmodium falciparum malaria therapy—a systematic review and meta-analysis , 2017, Parasitology Research.

[4]  U. Shaibu,et al.  Malaria and Agriculture: Examining the Cost Implications and Effect on Productivity among Farm Households in Kogi State, Nigeria , 2017 .

[5]  O. Ajumobi,et al.  Adherence to malaria diagnosis and treatment guidelines among healthcare workers in Ogun State, Nigeria , 2016, BMC Public Health.

[6]  O. Ajumobi,et al.  The role of drug vendors in improving basic health-care services in Nigeria , 2016, Bulletin of the World Health Organization.

[7]  D. Montagu,et al.  Improving the quality of paediatric malaria diagnosis and treatment by rural providers in Myanmar: an evaluation of a training and support intervention , 2015, Malaria Journal.

[8]  Jenny X. Liu,et al.  A Systematic Review of the Role of Proprietary and Patent Medicine Vendors in Healthcare Provision in Nigeria , 2015, PloS one.

[9]  A. Sowunmi,et al.  Efficacy of Artemisinin-Based Combination Treatments of Uncomplicated Falciparum Malaria in Under-Five-Year-Old Nigerian Children , 2014, The American journal of tropical medicine and hygiene.

[10]  Lindsay Jean Mangham Jefferies,et al.  Providers’ knowledge, preference and practice in treating patients with suspected malaria in Cameroon and Nigeria , 2014 .

[11]  C. Esimone,et al.  Drugs use pattern for uncomplicated malaria in medicine retail outlets in Enugu urban, southeast Nigeria: implications for malaria treatment policy , 2014, Malaria Journal.

[12]  I. Kleinschmidt,et al.  Understanding Private Sector Antimalarial Distribution Chains: A Cross-Sectional Mixed Methods Study in Six Malaria-Endemic Countries , 2014, PloS one.

[13]  V. Wiseman,et al.  What determines providers' stated preference for the treatment of uncomplicated malaria? , 2014, Social science & medicine.

[14]  A. Jegede,et al.  Awareness of antimalarial policy and use of artemisinin-based combination therapy for malaria treatment in communities of two selected local government areas of Ogun State, Nigeria. , 2014, World health & population.

[15]  D. Ansong,et al.  Effect of the Affordable Medicines Facility—malaria (AMFm) on the availability, price, and market share of quality-assured artemisinin-based combination therapies in seven countries: a before-and-after analysis of outlet survey data , 2012, The Lancet.

[16]  C. Goodman,et al.  Got ACTs? Availability, price, market share and provider knowledge of anti-malarial medicines in public and private sector outlets in six malaria-endemic countries , 2011, Malaria Journal.

[17]  O. Onwujekwe,et al.  Examining appropriate diagnosis and treatment of malaria: availability and use of rapid diagnostic tests and artemisinin-based combination therapy in public and private health facilities in south east Nigeria , 2010, BMC public health.

[18]  O. Ekwunife,et al.  Increasing use of artemisinin-based combination therapy for treatment of malaria infection in Nigerian hospitals , 2010, Pharmacy practice.

[19]  B. Uzochukwu,et al.  Improving childhood malaria treatment and referral practices by training patent medicine vendors in rural south-east Nigeria , 2009, Malaria Journal.

[20]  Nigeria.,et al.  Nigeria Demographic and Health Survey 2008 , 2004 .

[21]  W. Brieger,et al.  Primary care training for patent medicine vendors in rural Nigeria. , 1992, Social science & medicine.

[22]  S. Diawara,et al.  [Evaluation of the quality of prescription and dispensing of artemisinin-based therapeutic combinations in the Bamako District, Mali]. , 2010, Le Mali medical.